Aptose Biosciences. Inc. (NASDAQ:APTO) has 51 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange 3 Stocks Driving The Drugs Industry Higher · By TheStreet Wire. Jul 30, 2015 4: 33 PM EDT. We apologize for any inconvenience. Refresh or try again later. Date, Type, Description. 05/07/2020 17:00 EDT, Misc, Aptose Biosciences Inc First Quarter Earnings Conference Call in 2020. 05/07/2020, Earnings, Aptose Aptose Biosciences Inc $ 5.99 0 (0%). Volume: 709,780. Avg Vol (1m):. 1,055,236. Market Cap $:. 456.86 Mil. Enterprise Value $:. 366.64 Mil. P/E (TTM):. 0.00. Aptose Biosciences Inc quote is equal to 6.170 USD at 2020-04-08. Based on our forecasts, a long-term increase is expected, the "APTO" stock price prognosis for
APTO Real Time Stock Quote - Get Aptose Biosciences, Inc. Common Shares (APTO) last sale data in real-time at NASDAQ.com.
Mar 2, 2020 The shares of Aptose Biosciences Inc. (NASDAQ:APTO) has been pegged That day the Piper Sandler set price target on the stock to $10. APTO Stock Price | Aptose Biosciences Inc. Stock Quote (U ... Aptose Biosciences Inc. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Aptose Biosciences, Inc. (APTO) Stock Price, Quote ... Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing.
APTO:NASDAQ CM Stock Quote - Aptose Biosciences Inc ...
Get Aptose Biosciences Inc (APTO:NASDAQ) real-time stock quotes, news and financial information from CNBC. APTO - Stock quote for Aptose Biosciences Inc. - MSN Money View the latest APTO stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Aptose Biosciences Inc.. Aptose Biosciences, Inc. Common Shares (APTO) Earnings ...
View the latest APTO stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Aptose Biosciences Inc..
Aptose Biosciences, Inc. is estimated to report earnings on 03/10/2020. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. All News for APTO : Aptose Biosciences, Inc. - Zacks.com Aptose Biosciences, Inc. (APTO) Quote Overview » News » Aptose Biosciences, Inc. (APTO) Zacks News Zacks News Factors to Know Ahead of Talos Energy's (TALO) Q4 Earnings Aptose Biosciences, Inc. Common ... - Nasdaq Stock Market Find the latest analyst research for Aptose Biosciences, Inc. Common Shares (APTO) at Nasdaq.com. Aptose Biosciences Inc Stock Quote: APTO Stock News ... Nov 06, 2019 · APTO, Aptose Biosciences Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
Aptose Biosciences Inc. - Stockhouse
Aptose Biosciences Inc. Stock Price (APS) | Barron's View today's stock price, news and analysis for Aptose Biosciences Inc. (APS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and APTO: Aptose Biosciences, Inc. - Zacks Investment Research APTO: Aptose Biosciences, Inc. - Full Company Report. Get the latest Full Company Report for Aptose Biosciences, Inc. from Zacks Investment Research Stock To Watch: Aptose Biosciences (APTO) - Siomni™ Shares of Aptose Biosciences Inc. , which closed Tuesday’s trading at a new yearly high of $7.66, have gained 35 percent so far this year. Aptose Biosciences is a clinical-stage biotechnology company developing personalized therapies for hematologic diseases. The Company has two compounds in development – CG-806 and APTO-253.
Aptose Biosciences, Inc. (APTO) Interactive Stock Chart ...